Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Thompson
GE Healthcare
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Munich University Hospital
München, Germany
Not, yet, recruiting
- Papa Giovanni Xxiii Hospital
Bergamo, Italy
Not, yet, recruiting - Giannina Gaslini Institute
Genoa, Italy
Not, yet, recruiting
- University Hospitals Bristol and Weston Nhs Foundation Trust
Bristol, United Kingdom
Recruiting - Imperial College Healthcare Nhs Trust
London, United Kingdom
Recruiting - King'S College Hospital Nhs Foundation Trust
London, United Kingdom
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Jan 2025
- Primary completion
- 31 Jul 2026
- Completion
- 31 Oct 2026
- Last update posted
- 4 Mar 2026
- Registered enrollment
- 50
- Registry id
- NCT06639828
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.